Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(13%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_2

13%

Ph not_applicable

25%

Ph early_phase_1

25%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Early Phase 1First-in-human

2(28.6%)

Phase 2Efficacy & side effects

1(14.3%)

Phase 3Large-scale testing

2(28.6%)

N/ANon-phased studies

2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(1)

Other(2)

Detailed Status

Completed4

unknown2

Withdrawn1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Early Phase 12 (28.6%)

Phase 21 (14.3%)

Phase 32 (28.6%)

N/A2 (28.6%)

Trials by Status

unknown225%

completed450%

withdrawn113%

recruiting113%

Recent Activity

1 active trials

Showing 5 of 8

recruitingearly_phase_1

Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

NCT03905603

unknownnot_applicable

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

NCT01422733

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT03905603Early Phase 1

Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Recruiting

NCT01421810Not Applicable

Ovarian Contribution to Androgen Production in Adolescent Girls

Unknown

NCT05969834

HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

Completed

NCT01112358Phase 2

Lutropin Alfa in Women at Risk of Poor Response

Completed

NCT01422733Early Phase 1

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

Withdrawn

NCT02635607Not Applicable

Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol

Unknown

NCT01081756Phase 3

A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)

Completed

NCT01718119Phase 3

Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8